Quidel | QDEL - Операционный доход





Операционный доход Изменить Дата
Abbott USD 1.85B 399M 2026-03
Agilent USD 399M 46M 2026-03
Avanos Medical USD 8.9M 15.87M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Danaher USD 1.34B 158M 2026-03
Haemonetics USD 67.4M 8.9M 2025-12
Illumina USD 239M 17M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Neogen USD -3.3M 2.08M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quidel USD -31.8M 5.5M 2026-03
Revvity USD 82.77M 63.06M 2026-03
STAAR Surgical USD 17.4M 28.34M 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 148M 122.52M 2026-03